Published in Blood on February 01, 1992
Quantitative analysis of globin gene induction in single human erythroleukemic cells. Nucleic Acids Res (2000) 0.95
Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase. J Biol Chem (1994) 1.20
Effects of stathmin inhibition on the mitotic spindle. J Cell Sci (2001) 1.13
Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species. J Biol Chem (1989) 1.12
Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. Cancer Res (1996) 1.11
Intracranial solitary extraskeletal plasmacytoma resembling meningioma. Arch Neurol (1982) 1.10
Beta-thalassemia resulting from a single nucleotide substitution in an acceptor splice site. Nucleic Acids Res (1985) 1.09
Prevalence of sleep apnea in men with erectile dysfunction. Urology (1990) 1.04
A new mutation in IVS-1 of the human beta globin gene causing beta thalassemia due to abnormal splicing. Blood (1987) 1.00
Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin. Biochem J (1998) 1.00
Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle. Cancer Res (2000) 0.97
Erythropoietin receptor contributes to melanoma cell survival in vivo. Oncogene (2011) 0.96
Expression of the leukemia-associated gene, p18, in normal and malignant tissues; inactivation of expression in a patient with cleaved B cell lymphoma/leukemia. Oncogene (1993) 0.93
Production of genetically stable high-titer retroviral vectors that carry a human gamma-globin gene under the control of the alpha-globin locus control region. Blood (1996) 0.92
WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene (1999) 0.92
Regulated expression of p18, a major phosphoprotein of leukemic cells. J Biol Chem (1991) 0.91
Stathmin inhibition enhances okadaic acid-induced mitotic arrest: a potential role for stathmin in mitotic exit. J Biol Chem (2001) 0.90
The major regulatory element upstream of the alpha-globin gene has classical and inducible enhancer activity. Blood (1993) 0.90
The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene (1995) 0.84
Increased expression of the G gamma and A gamma globin genes associated with a mutation in the A gamma enhancer. Blood (1994) 0.81
A gene that encodes for a leukemia-associated phosphoprotein (p18) maps to chromosome bands 1p35-36.1. Genes Chromosomes Cancer (1990) 0.81
In vivo silencing of the human gamma-globin gene in murine erythroid cells following retroviral transduction. Blood Cells Mol Dis (2000) 0.81
Resolving conflicts: misconceptions and myths in the care of the patient with sickle cell disease. Mt Sinai J Med (1999) 0.81
Transcriptional regulation of phosphoprotein p18 during monocytic differentiation of U937 leukemic cells. Cell Mol Biol Res (1995) 0.80
A novel basis for delta beta-thalassemia in a Chinese family. Blood (1986) 0.80
CACCC and GATA-1 sequences make the constitutively expressed alpha-globin gene erythroid-responsive in mouse erythroleukemia cells. Nucleic Acids Res (1996) 0.79
The prevalence of periodic limb movements during sleep in men with erectile dysfunction. Biol Psychiatry (1989) 0.79
A novel regulatory element of the human alpha-globin gene responsible for its constitutive expression. J Biol Chem (1991) 0.79
Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells. Mol Genet Metab (1998) 0.79
Identification of a beta-thalassemia mutation associated with a novel haplotype of RFLPs. Am J Hum Genet (1986) 0.79
Development of ribozymes that target stathmin, a major regulator of the mitotic spindle. Antisense Nucleic Acid Drug Dev (2001) 0.78
Nocturnal penile tumescence in cigarette smokers with erectile dysfunction. Urology (1992) 0.78
The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells. Blood (1998) 0.78
Stathmin expression in immortalized and oncogene transformed cells. Anticancer Res (1999) 0.77
Clinical and molecular correlations in the sickle/beta+-thalassemia syndrome. Am J Hematol (1987) 0.76
Familial polycythemia due to truncations of the erythropoietin receptor. Trans Am Clin Climatol Assoc (2000) 0.76
Coronary care experience in a university hospital. Middle East J Anaesthesiol (1979) 0.75
Abnormal processing of beta-Malay globin RNA. Biochem Biophys Res Commun (1989) 0.75